Natural COVID-19 Infection Produces Robust T Cell Response and Memory to Fight Future Infections, Finds Study
Researchers from the University of Oxford (Oxford, UK) have found that natural infection with COVID-19 produces a robust T cell response, including inducing T cell ‘memory’ to potentially fight future infections. More...08 Sep 2020
First-Ever Commercially Available COVID-19 Seroconversion Panel to Confirm Presence of Anti-SARS-CoV-2 Antibodies Completed
Access Biologicals (Vista, CA, USA) has completed the first-ever commercially available COVID-19 seroconversion panel to confirm the presence of anti-SARS-CoV-2 antibodies that will assist diagnostic manufacturers and researchers during assay development and evaluation, as well as troubleshooting COVID-19-test methods. More...08 Sep 2020
Stool Test Could Better Detect COVID-19 than Traditional Nose Swabs Due to Prolonged Gut Viral Infection
Researchers have found for the first time that COVID-19 patients have active and prolonged gut viral infection, suggesting that stool tests could be more safe, accurate and non-invasive than traditional nose swabs in detecting coronavirus. More...08 Sep 2020
Groundbreaking RNA Extraction-Free qSanger-COVID-19 Assay Secures FDA EUA
A groundbreaking SARS-CoV-2 diagnostic test which eliminates the costly and time-consuming step of RNA extraction has been granted Emergency Use Authorization (EUA) by the US Food and Drug Administration (FDA). More...08 Sep 2020
Russia’s Sputnik V COVID-19 Vaccine Deals Double Blow to Coronavirus in Phase 1 and 2 Clinical Trials
Results from the first two phases of clinical trials of two different forms of Russia’s Sputnik V COVID-19 vaccine show that both the vaccine formulations proved almost equally effective and caused all participants to develop antibodies to the novel coronavirus, as well as taught T-cells to recognize this threat. More...08 Sep 2020
Fujifilm Sonosite Receives FDA COVID-19 510(k) Clearance for POC Ultrasound Portfolio
FUJIFILM Sonosite, Inc. (Bothell, WA, USA) has received 510(k) Clearance from the US Food & Drug Administration (FDA) for its point-of-care ultrasound (POCUS) portfolio to support healthcare providers in performing accurate lung and cardiac imaging in COVID-19 patients. More...07 Sep 2020
Heart Cells Could Serve as New Drug Screen for COVID-19 Treatment
A study by scientists at Gladstone Institutes (San Francisco, CA, USA) explains how SARS-CoV-2 inflicts damage on heart cells, and shows the virus’s unexpected effects on the structure of heart cells in the lab, as well as in heart tissue from COVID-19 patients. More...07 Sep 2020
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
Hospital Data Analytics Software
OR Companion
New
Transducer Covers
Surgi Intraoperative Covers
In Other News
Oversensitive COVID-19 Tests Detecting Dead Coronavirus Cells, Driving False Positives and Reinfections
Researchers Identify ‘Nanobodies’ That Can Block Novel Coronavirus from Entering Human Cells
COVID-19 Vaccine Developers to Issue Joint Public Pledge Against Premature Launch Before Proving Safety and Effectiveness
Pfizer Could Seek FDA Emergency Use Authorization for COVID-19 Vaccine in October
Novavax COVID-19 Vaccine Phase 1 Data Reaffirms Safety Profile and Ability to Elicit Immune Response
J&J’s Lead COVID-19 Vaccine Candidate Prevents Severe Disease in Pre-Clinical Studies
Roche Receives FDA EUA for Cobas SARS-CoV-2 & Influenza A/B Test for Use on Cobas 6800/8800 Systems
Chest X-Rays Can Aid in Rapid Diagnosis of COVID-19, Find Radiologists
Researchers Identify New Possible Entry Points for SARS-CoV-2 into Human Bodies
High-Powered Microscopic Images Reveal Startlingly High SARS-CoV-2 Viral Loads on Human Respiratory Surfaces
NIH Offers USD 129.3 Million in Scale-Up and Manufacturing Support for New Set of COVID-19 Testing Technologies
WHO Recommends Corticosteroids for Treatment of Critically Ill COVID-19 Patients After New Findings Emerge
Sanofi and GSK Begin Phase 1/2 Trial of COVID-19 Vaccine Candidate with Aim to Move into Phase 3 by 2020 End
Next-Generation Lymph Node Targeting COVID-19 Vaccine Promises Enduring T Cell Immunity
New Promega XpressAmp Direct Amplification Reagents Allow COVID-19 Testing Labs to Skip RNA Extraction
MicroGEM Awarded Over USD 40 Million by NIH to Fast-Track Rapid, No-Lab COVID-19 Saliva Test
Combining PCR and Antibody Tests at POC Dramatically Increases COVID-19 Detection in Hospitalized Patients
COVID-19 Vaccine Trials Could Be Halted Early in Case of Overwhelmingly Positive of Negative Results, Says Anthony Fauci
SARS-CoV-2 Found in Blood Test on Hospital Admission Can Predict Severe COVID-19
ThermoGenesis Launches Comprehensive Suite of COVID-19 Products and Services to Better Detect, Track and Fight Novel Coronavirus
Minimal Mutation in SARS-CoV-2 Suggests Only One COVID-19 Vaccine May Be Sufficient to Combat Global Infections
Study Finds Coronavirus Immunity Lasts Four Months after Infection, Offering Hope for COVID Vaccine Efforts
Roche to Launch 15-Minute COVID-19 Rapid Antigen Test in Europe and File for EUA in US
